Methods for using specific saccharides for treating Alzheimer's disease and other amyloidoses
AssigneeUniversity of Washington
InventorsGerardo M. Castillo, Alan D. Snow
Life of this patent
Estimating the term…
Abstract
A pharmaceutical agent for treating an amyloid disease in a patient, wherein the pharmaceutical agent comprises a glucose monosaccharide containing at least one anionic group, or a pharmaceutically acceptable salt thereof. The agent is directed to amyloid diseases in general and to Alzheimer's disease in particular. Methods of treating an amyloid disease in a patient by administering therapeutically effective amounts of a glucose monosaccharide containing at least one anionic group are also presented.
Claims6
A method of treating an amyloid disease in a patient, comprising a step of administering to the patient a therapeutically effective amount of a glucose monosaccharide comprised of at least one anionic group, a pharmaceutically acceptable salt thereof, or a related derivative thereof.
Dependencies are inferred from the claim text.